Persistent Antiphospholipid Antibodies, Mast Cell Activation Syndrome, Postural Orthostatic Tachycardia Syndrome and Post-COVID Syndrome: 1 Year On

Persistent Antiphospholipid Antibodies, Mast Cell Activation Syndrome, Postural Orthostatic Tachycardia Syndrome and Post-COVID Syndrome: 1 Year On

This is the first case report of a patient with post-COVID-19 postural orthostatic tachycardia syndrome (POTS) with multiple persistent antiphospholipid antibody (aPL)-positivity more than a year after illness onset who also meets Global Consensus-2 criteria for mast cell activation syndrome (MCAS),...

Full description

Bibliographic Details
Main Author: Jill Schofield
Format: Article
Language:English
Published: SMC MEDIA SRL 2021-03-01
Series:European Journal of Case Reports in Internal Medicine
Subjects:
long-haul covid-19
antiphospholipid antibodies
postural orthostatic tachycardia syndrome
mast cell activation syndrome
post-covid syndrome
Online Access:https://www.ejcrim.com/index.php/EJCRIM/article/view/2378

Internet

https://www.ejcrim.com/index.php/EJCRIM/article/view/2378

Similar Items